This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Hardy RR , Hayakawa K
Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes
Springer Seminars in Immunopathology. 2005 Mar;26(4) :363-375
AbstractNatural antibodies produced by CD5(+) B- I B cells include those with specificity for senescent erythrocytes (anti-BrMRBC, anti-PtC) and for thymocytes (anti -thymocyte autoantibody, ATA). Here we describe work from our laboratories Studying two prototypic examples, V(H)11V(kappa)9-encoded anti-BrMRBC and V(H)3609V(kappa)2 I c-encoded ATA. Using V(H)11 -mu transgenic mice, we discovered that certain natural autoantibodies utilize V-H genes that are selected against in bone marrow B cell development, but not fetal liver, effectively restricting their generation to fetal/neonatal life. Studies with ATA-mu transgenic mice demonstrated a critical requirement for self antigen ill the accumulation of B cells with this specificity and for the production of high levels of serum ATA. Finally, analysis of B cell development in ATA-mu kappa transgenic mice revealed two distinct responses by B cells to expression of this B cell receptor (BCR): most developing B cells in spleen of adult mice were blocked at an immature stage and only escaped apoptosis by editing their BCR to eliminate the ATA specificity; nevertheless, high levels of serum ATA were observed, indicating that some B cells differentiated to antibody-forming cells without altering their specificity. Thus, our studies reveal mechanisms for restricting the generation of B cells producing natural autoantibodies, demonstrate a key positive selection step in their development, and show that most developing B cells in adult mice bearing such specificities fail to reach a mature stage.